Nebivolol, carvedilol and metoprolol do not influence cardiac Ca2+ sensitivity

被引:7
作者
Bundkirchen, A [1 ]
Brixius, K [1 ]
Bölck, B [1 ]
Mehlhorn, U [1 ]
Bloch, W [1 ]
Schwinger, RHG [1 ]
机构
[1] Univ Cologne, Innere Med Klin 3, Lab Herzmuskelphysiol & Mol Kardiol, D-50924 Cologne, Lindenthal, Germany
关键词
Ca2+ sensitivity; beta-adrenoceptor antagonist; nebivolol; heart failure; myocardium; human;
D O I
10.1016/S0014-2999(01)01082-2
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
It has been argued that some P-adrenoceptor antagonists may directly influence myofibrillar cross-bridge interaction in cardiac skinned fiber preparations of animal models. The present study investigates the effects of nebivolol, metoprolol and carvedilol on tension development of Triton X-100 skinned fibers obtained from human failing myocardium as well as on force of contraction and intracellular Ca2+ transient in isolated trabeculae. In skinned fiber preparations, none of the beta -adrenoceptor antagonists (10 muM) influenced Ca2+ sensitivity of tension development or maximal Ca2+ activated tension (DTmax): control: EC50 for Ca2+: 1.28 +/- 0.05 muM. DTmax: 14.09 +/- 0.59 mN/mm(2), nebivolol: 1.36 +/- 0.1 muM, 14.14 +/- 0.95 mN/mm(2); carvedilol: 1.32 +/- 0.11 muM, 13.83 +/- 0.90 mN/mm(2) metoprolol: 1.34 +/- 0.14 muM, 13.72 +/- 0.36 mN/mm(2). Simultaneous measurement of force and Ca2+ transient in the presence of the beta -adrenoceptor antagonists (3 muM) showed that the decrease in force of contraction was paralleled by a similar decrease in the intracellular Ca2+ transient. In conclusion, none of the investigated P-adrenoceptor antagonists influenced Ca2+ sensitivity of myofibrillar tension development in human failing myocardium. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 21 条
[1]
INTRACELLULAR CALCIUM HANDLING IN ISOLATED VENTRICULAR MYOCYTES FROM PATIENTS WITH TERMINAL HEART-FAILURE [J].
BEUCKELMANN, DJ ;
NABAUER, M ;
ERDMANN, E .
CIRCULATION, 1992, 85 (03) :1046-1055
[2]
β-adrenergic receptor blockade in chronic heart failure [J].
Bristow, MR .
CIRCULATION, 2000, 101 (05) :558-569
[3]
Brixius K, 2000, J PHARMACOL EXP THER, V295, P1284
[4]
Effect of inotropic interventions on contraction and Ca2+ transients in the human heart [J].
Brixius, K ;
Pietsch, M ;
Hoischen, S ;
MullerEhmsen, J ;
Schwinger, RHG .
JOURNAL OF APPLIED PHYSIOLOGY, 1997, 83 (02) :652-660
[5]
DECREE J, 1992, INT J CLIN PHARM RES, V12, P159
[6]
EFFECTS OF LEVOSIMENDAN, A CARDIOTONIC AGENT TARGETED TO TROPONIN-C, ON CARDIAC-FUNCTION AND ON PHOSPHORYLATION AND CA2+ SENSITIVITY OF CARDIAC MYOFIBRILS AND SARCOPLASMIC-RETICULUM IN GUINEA-PIG HEART [J].
EDES, I ;
KISS, E ;
KITADA, Y ;
POWERS, FM ;
PAPP, JG ;
KRANIAS, EG ;
SOLARO, RJ .
CIRCULATION RESEARCH, 1995, 77 (01) :107-113
[7]
FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463
[8]
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[9]
Cellular and molecular remodeling in a heart failure model treated with the β-blocker carteolol [J].
Gwathmey, JK ;
Kim, CS ;
Hajjar, RJ ;
Khan, F ;
DiSalvo, TG ;
Matsumori, A ;
Bristow, MR .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (05) :H1678-H1690
[10]
Hjalmarson Å, 1999, LANCET, V353, P2001